公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2010 | Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma | CHIH-HUNG HSU ; Yang T.-S.; CHIUN HSU ; Toh H.C.; Epstein R.J.; Hsiao L.-T.; PEI-JER CHEN ; ZHONG-ZHE LIN ; Chao T.-Y.; ANN-LII CHENG | British Journal of Cancer | 114 | 112 | |
2017 | Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes | WEN-CHIEN CHOU ; Yeh S.-P.; Hsiao L.-T.; Lin S.-F.; Chen Y.-C.; Chen T.-Y.; Laille E.; Galettis A.; Dong Q.; Songer S.; Beach C.L. | Asia-Pacific Journal of Clinical Oncology | 6 | 4 | |
2012 | A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system | Yu Y.-B.; Gau J.-P.; Liu C.-Y.; Yang M.-H.; Chiang S.-C.; Hsu H.-C.; Hong Y.-C.; Hsiao L.-T.; Liu J.-H.; Chiou T.-J.; Chen P.-M.; TZONG-SHYUAN LEE ; Chou L.-F.; Tzeng C.-H.; Chen T.-J. | Thrombosis and Haemostasis | 89 | 89 | |
2015 | Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma | Hsiao L.-T.; HWEI-FANG TIEN ; Kuo C.-Y.; Wu J.-H.; HSIN-AN HOU ; Wang M.-C.; Liu C.-Y.; Chen P.-M.; Chiou T.-J. | Hematological Oncology | 1 | 1 | |
2022 | Stem cell transplant for mantle cell lymphoma in Taiwan | Wang Y.-H.; Hsieh C.-Y.; Hsiao L.-T.; Lin T.-L.; Liu Y.-C.; MING YAO ; Tan T.-D.; BOR-SHENG KO | Scientific Reports | 1 | 0 |